Quality of Life Questionnaire-Bronchiectasis: a study of the psychometric properties of the Brazilian Portuguese version

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Autores
CAMARGO, Cristiane O. de
JOSE, Anderson
LUPPO, Adriano
CAMARGO, Anderson A. de
QUITTNER, Alexandra L.
CORSO, Simone Dal
Citação
CLINICAL REHABILITATION, v.34, n.7, p.960-970, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To evaluate the psychometric properties of the Brazilian Portuguese version of the Quality of Life Questionnaire-Bronchiectasis. Design: Cross-sectional study. Setting: Outpatient clinic. Subjects: Clinically stable individuals with a diagnosis of bronchiectasis. Measures: The evaluations performed were spirometry, incremental shuttle walk test, Saint George's Respiratory Questionnaire, and the modified Medical Research Council dyspnea scale. The Quality of Life Questionnaire-Bronchiectasis was administered twice (seven to 14 days apart). Psychometric analyses were performed as follows: reliability, construct validity, criterion validity, and interpretability. Results: In total, 108 individuals (48 +/- 14 years, 61 women) participated in the study. Internal consistency was considered adequate (Cronbach's alpha > 0.70) for the majority of scales (from 0.58 to 0.93). Test-retest coefficients were moderate to excellent (intraclass correlation coefficients from 0.70 to 0.93). In the construct validity, 35 of 37 items correlated more strongly with their assigned scale than a competing scale. The convergent validity showed significant correlations between scales of the Quality of Life Questionnaire-Bronchiectasis with modified Medical Research Council dyspnea scale, and incremental shuttle walk test (r from 0.20 to 0.59). A low to moderate correlations was revealed between all scales of the Quality of Life Questionnaire-Bronchiectasis and the Saint George's Respiratory Questionnaire domains (r from 0.26 to 0.70). The standard error of measurement was acceptable. Ceiling effects were found for the Social Functioning and Treatment Burden scales. Conclusions: The Quality of Life Questionnaire-Bronchiectasis is a reliable, valid instrument with adequate internal consistency for the evaluation of the impact of bronchiectasis on the health-related quality of life of Brazilian adults.
Palavras-chave
Bronchiectasis, quality of life, validation studies, reproducibility of results
Referências
  1. ACQUADRO C, 1996, QUALITY LIFE PHARMAC, P575
  2. Baldi B. G., 2012, Jornal Brasileiro de Pneumologia, V38, pS1
  3. Bradley JM, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0046-7
  4. de Vet HCWT, 2011, MEASUREMENT MED PRAC, P96
  5. Dudgeon EK, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0631-7
  6. Hill AT, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00051-2017
  7. JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321
  8. Kovelis Demetria, 2008, J. bras. pneumol., V34, P1008, DOI 10.1590/S1806-37132008001200005
  9. Lanza FC, 2018, COPD, V15, P512, DOI 10.1080/15412555.2018.1540034
  10. Magge A, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.06.62
  11. Martinez-Garcia MA, 2017, INT J CHRONIC OBSTR, V12, P275, DOI 10.2147/COPD.S121943
  12. Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739
  13. Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8
  14. Murray MP, 2009, EUR RESPIR J, V34, P125, DOI 10.1183/09031936.00160508
  15. Olveira C, 2014, QUAL LIFE RES, V23, P1279, DOI 10.1007/s11136-013-0560-0
  16. Olveira C, 2013, QUAL LIFE RES, V22, P597, DOI 10.1007/s11136-012-0188-5
  17. Polit DF, 2015, INT J NURS STUD, V52, P1746, DOI 10.1016/j.ijnurstu.2015.07.002
  18. Quittner AL, 2010, AM J RESP CRIT CARE, V181
  19. Quittner AL, 2015, THORAX, V70, P12, DOI 10.1136/thoraxjnl-2014-205918
  20. Quittner AL, 2014, CHEST, V146, P437, DOI 10.1378/chest.13-1891
  21. SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019
  22. Spencer S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012579.pub2
  23. Spinou A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01532-2016
  24. Spinou A, 2016, THORAX, V71, P683, DOI 10.1136/thoraxjnl-2015-207315
  25. Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
  26. U.S. Food and Drug Administration, 2009, GUID IND PAT REP OUT
  27. Vodanovich DA, 2015, RESPIRATION, V90, P89, DOI 10.1159/000430992
  28. Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x
  29. Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083